Possible Influence of Vitamin D Receptor Gene Polymorphisms on Recombinant Human Erythropoietin Requirements in Dialysis Patients

Transplantation Proceedings

Volumn 39, Issue 1, 2007, Pages 40-44

  Sezer, S ^a   Tutal, E ^a   Bilgic, A ^a   Ozdemir, F N ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN; IRON; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; VITAMIN D RECEPTOR;

ADULT; ANEMIA; ARTICLE; BSM1 GENE; CALCIUM METABOLISM; CHRONIC INFLAMMATION; DNA POLYMORPHISM; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENOTYPE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

ADULT; ERYTHROPOIETIN; FEMALE; FERRITINS; GENOTYPE; HEMOGLOBINS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INFUSIONS, INTRAVENOUS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT SELECTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RENAL DIALYSIS; TRANSFERRIN;

EID: 33846593857     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.214     Document Type: Article

References (25)

1. Collins A.J., Ma J.Z., and Ebben J. Impact of hematocrit on morbidity and mortality. Semin Nephrol 20 (2000) 345
2. Esbach J.W., Downing M.R., Egrie J.C., et al. US multicenter clinical trial with recombinant human erythropoietin. Contrib Nephrol 76 (1989) 160
3. Stenvinkel P., and Barany P. Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 17 suppl 5 (2002) 32
4. National Kidney Foundation. DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am J Kidney Dis 30 suppl 3 (1997) S192
5. Working Party for European Best Practice Guidelines for the Management of Anemia in Patients With Chronic Renal Failure. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 14 suppl 5 (1999) S1
6. Macdougall I.C. Poor response to erythropoietin: practical guideline on investigation and management. Nephrol Dial Transplant 10 (1995) 607
7. Drueke T.B. R-HuEpo hyporesponsiveness-who and why?. Nephrol Dial Transplant 10 suppl 2 (1995) S62
8. Nagler A., Riklis I., Kletter Y., et al. Effect of 1,25-dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns. Exp Hematol 14 (1986) 60
9. Moore D.C., Carter D.L., Bhandal A.K., et al. Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells. Blood 77 (1991) 1452
10. Albitar S., Genin R., Fen-Chong M., et al. High-dose alfacalcidol improves anaemia in patients on haemodialysis. Nephrol Dial Transplant 12 (1997) 514
11. Goicoechea M., Vazquez M.I., Ruiz M.A., et al. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron 78 (1998) 23
12. Glorieux G., and Vanholder R. Blunted response to vitamin D in uremia. Kidney Int 59 suppl 78 (2001) S182
13. Depner T.A. Prescribing Hemodialysis: A Guide to Urea Modeling (1991), Kluwer, Boston, MA p 65
14. Sosa M., Torres A., and Martin N. The distribution of two different vitamin D receptor polymorphisms in primary hyperparathyroidism. J Internal Med 247 (2000) 124
15. Lundin A., Söderkvist P., and Erikson B. Association of breast cancer progression with a vitamin D receptor gene polymorphism. Cancer Research 59 (1999) 2332
16. Zmuda J.M., Cauley J.A., and Farrel R.E. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 22 (2000) 203
17. Carling T., Kindmark A., Hellman P., et al. Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN I. Biochem Biophys Res Commun 231 (1997) 329
18. Fernandez A., Fibla J., Betriu A., et al. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol 8 (1997) 1546
19. Tagliabue J., Farina M., Imbasciati E., et al. Bsml polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients. Am J Clin Pathol 112 (1999) 366
20. Nagaba Y., Heishi M., Tazawa H., et al. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis 32 (1998) 464
21. Ozdemir F.N., Sezer S., Atac B., et al. Vitamin D receptor Bsml and Tagl gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Transplant Proc 37 (2005) 2922
22. Fraser D.R. Vitamin D. Lancet 345 (1995) 104
23. Bhalla A.K., Paavonen T., Williams M.M., et al. Regulation of interleukin-1 and tumor necrosis factor gene expression in myelomonocytic cell lines by 1,25-dihydroxyvitamin D3. Immunology 72 (1991) 61
24. Goicoechea M., Martin J., De Sequera P., et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54 (1998) 1337
25. Ertürk S., Kutlay S., Karabulut H.G., et al. The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients. Am J Kidney Dis 40 (2002) 816